Gene Predictis and Synlab Switzerland Announce Strategic Commercial Partnership Regarding Genetic Tests Distribution

Gene Predictis and Synlab Switzerland Announce Strategic Commercial Partnership Regarding Genetic Tests Distribution

03.9.2018 – Gene Predictis SA and Synlab Switzerland SA announce a strategic partnership to jointly commercialize an innovative genetic test allowing measuring the risk of thrombosis related to use of combined oral contraceptives. The companies will collaborate to promote and provide the test in Switzerland and thus empower the existing women’s health offerings in Switzerland and improve the service to physicians and women.

Read the complete presse release